Immunohistochemical (IHC) analyses indicated a marked decrease in GPX4, a key ferroptosis marker, following ART exposure, alongside a significant suppression of Ki67, indicative of reduced proliferation in DLBCL (Fig. 6H). The gene discussed is GPX4; the disease is diffuse large B-cell lymphoma.